Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Genetic polymorphisms located in genes related to immune and inflammatory processes are associated with end-stage renal disease: a preliminary study.

Jimenez-Sousa MA, López E, Fernandez-Rodríguez A, Tamayo E, Fernández-Navarro P, Segura-Roda L, Heredia M, Gómez-Herreras JI, Bustamante J, García-Gómez JM, Bermejo-Martin JF, Resino S.

BMC Med Genet. 2012 Jul 20;13:58. doi: 10.1186/1471-2350-13-58.

2.

Association of chemokine gene variants with end stage renal disease in North Indian population.

Singh V, Jaiswal PK, Tiwari P, Kapoor R, Mittal RD.

Transpl Immunol. 2013 Jun;28(4):189-92. doi: 10.1016/j.trim.2013.04.004. Epub 2013 Apr 21.

PMID:
23615182
3.

Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.

El-Din Bessa SS, Hamdy SM.

Ren Fail. 2011;33(9):878-84. doi: 10.3109/0886022X.2011.605978. Epub 2011 Aug 22.

PMID:
21854353
4.

Genetic analysis of nitric oxide and endothelin in end-stage renal disease.

Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW.

Nephrol Dial Transplant. 2000 Nov;15(11):1794-800.

PMID:
11071967
5.

Association of endothelial nitric oxide synthase gene polymorphisms with end-stage renal disease: a systematic review and meta-analysis.

Yun Z, Yu-Ping Y, Zong-Wu T, Yang S, Fang Y, Fang S.

Ren Fail. 2014 Jul;36(6):987-93. doi: 10.3109/0886022X.2014.900601. Epub 2014 Mar 27. Review.

PMID:
24673298
6.

Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.

Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A.

Nephrol Dial Transplant. 2006 Apr;21(4):979-83. Epub 2005 Dec 29.

PMID:
16384824
7.

Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis.

de Souza CM, Braosi AP, Luczyszyn SM, Avila AR, de Brito RB Jr, Ignácio SA, Probst CM, Riella MC, Sotomaior VS, Mira MT, Pecoits-Filho R, Trevilatto PC.

Blood Purif. 2007;25(5-6):411-9. Epub 2007 Oct 3.

PMID:
17914260
8.

Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease.

Kim YG, Kim EY, Ihm CG, Lee TW, Lee SH, Jeong KH, Moon JY, Chung JH, Kim YH.

Am J Nephrol. 2012;36(5):472-7. doi: 10.1159/000343571. Epub 2012 Nov 7.

PMID:
23147652
9.

Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease.

Maruyama Y, Nordfors L, Stenvinkel P, Heimburger O, Bárány P, Pecoits-Filho R, Axelsson J, Hoff CM, Holmes CJ, Schalling M, Lindholm B.

Blood Purif. 2005;23(5):384-93. Epub 2005 Jul 27.

PMID:
16088107
10.

Role of non-HLA genetic variants in end-stage renal disease.

Ranganath P, Tripathi G, Sharma RK, Sankhwar SN, Agrawal S.

Tissue Antigens. 2009 Aug;74(2):147-55. doi: 10.1111/j.1399-0039.2009.01276.x. Epub 2009 Jun 2.

PMID:
19497039
11.

Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.

Enjuanes A, Benavente Y, Hernández-Rodríguez J, Queralt C, Yagüe J, Jares P, de Sanjosé S, Campo E, Cid MC.

Rheumatology (Oxford). 2012 May;51(5):841-51. doi: 10.1093/rheumatology/ker429. Epub 2012 Jan 17.

PMID:
22258388
12.

A genetic predisposition to produce low levels of IL-10 is related to depressive symptoms: a pilot study of patients with end stage renal disease.

Holtzman S, Abbey SE, Chan C, Bargman JM, Stewart DE.

Psychosomatics. 2012 Mar-Apr;53(2):155-61. doi: 10.1016/j.psym.2011.10.001.

PMID:
22424164
13.

Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease.

Thaha M, Pranawa, Yogiantoro M, Sutjipto, Sunarjo, Tanimoto M, Gohda T, Tomino Y.

Clin Nephrol. 2008 Aug;70(2):144-54.

PMID:
18793530
14.

Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study.

Yang HY, Lu KC, Lee HS, Huang SM, Lin YF, Wu CC, Salter DM, Su SL.

PLoS One. 2013;8(3):e58444. doi: 10.1371/journal.pone.0058444. Epub 2013 Mar 5.

15.

Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease.

Bellini MH, Figueira MN, Piccoli MF, Marumo JT, Cendoroglo MS, Neto MC, Dalboni MA, Batista MC, Goes MA, Schor N.

Nephrology (Carlton). 2007 Jun;12(3):289-93.

PMID:
17498125
16.
17.

Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide.

Dahgam S, Nyberg F, Modig L, Naluai AT, Olin AC.

J Med Genet. 2012 Mar;49(3):200-5. doi: 10.1136/jmedgenet-2011-100584.

PMID:
22368302
18.

Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.

Buraczynska K, Koziol-Montewka M, Majdan M, Tokarz A, Ksiazek A.

Ren Fail. 2004 Nov;26(6):633-9.

PMID:
15600254
19.

Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients.

Zsom M, Fülöp T, Zsom L, Baráth A, Maróti Z, Endreffy E.

Hemodial Int. 2011 Oct;15(4):501-8. doi: 10.1111/j.1542-4758.2011.00593.x. Epub 2011 Sep 13.

PMID:
22111818
20.

Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease.

Elshamaa MF, Sabry S, Badr A, El-Ahmady M, Elghoroury EA, Thabet EH, Kandil D, Kamel S.

Blood Coagul Fibrinolysis. 2011 Sep;22(6):487-92. doi: 10.1097/MBC.0b013e328346ef71.

PMID:
21519233

Supplemental Content

Support Center